Methotrexate
NDC 59651-182, Methotrexate, tablet, from Aurobindo Pharma Limited.
- Product NDC
- 59651-182
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210454
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59651-182 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METHOTREXATE SODIUM2.5 mg/1
Pharmacologic classes
Folate Analog Metabolic Inhibitor [EPC]; Folic Acid Metabolism Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59651-182-01 | 59651018201 | 100 TABLET in 1 BOTTLE (59651-182-01) |
| 59651-182-36 | 59651018236 | 36 TABLET in 1 BOTTLE (59651-182-36) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/09931d44-a3f8-49dc-a3f2-b527ee4214bfMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=59651-182NADAC price for package 59651018201
GET /v1/drugs/nadac/59651018201
Use it
Look up 59651-182 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59651-182 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59651-182. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.